The Medical Marijuana Market is segmented according to formulation type, cannabinoid composition, route of administration, application, distribution channel, end use, and region.

By formulation, the market includes cannabinoid oils, dried flowers, edibles, tinctures, topicals, and other formats. Oils accounted for 45.2% of market revenue in 2025, supported by demand for controlled dosing and convenient administration.

By cannabinoid composition, CBD-dominant products represented 46.1% of the market in 2025. THC-dominant formulations are also expected to expand rapidly as research and medical applications continue to develop.

By route of administration, oral delivery held the largest share at 47.8% in 2025. Sublingual delivery is expected to gain popularity because of its rapid absorption and convenient administration.

By application, chronic pain represented the largest segment, followed by neurological disorders, arthritis, migraine, oncology, and other medical conditions.

By distribution channel, retail dispensaries accounted for the largest share, while online platforms are projected to register strong growth through 2035.

Regionally, North America held the largest share in 2025, while Asia-Pacific is projected to record the fastest growth at a 17.5% CAGR during the forecast period.